Accordingly, we found that carriers with CG genotype of IL-4 rs2243283 had a statistically decreased risk of AD than carriers with CC genotype (P = 0.024; OR = 0.47, 95% CI = 0.27–0.81). This evidence concerns the gene IL4 and Alzheimer disease.